All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
NLTX / Neoleukin Therapeutics, Inc.
|
|
|
|
|
|
|
|
SONX / Sonendo, Inc.
|
|
|
|
|
|
|
|
IMGN / ImmunoGen, Inc.
|
|
|
|
|
|
|
|
AKRO / Akero Therapeutics, Inc.
|
|
|
|
|
|
|
|
GRFS / Grifols, S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
FATE / Fate Therapeutics, Inc.
|
|
|
|
|
|
|
|
ZBH / Zimmer Biomet Holdings, Inc.
|
|
|
|
|
|
|
|
ZYME / Zymeworks Inc.
|
|
|
|
|
|
|
|
CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
CABA / Cabaletta Bio, Inc.
|
|
|
|
|
|
|
|
XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
STVN / Stevanato Group S.p.A.
|
|
|
|
|
|
|
|
DCPH / Deciphera Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
SLGC / Standard BioTools Inc.
|
|
|
|
|
|
|
|
SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
OSH / Oak Street Health Inc
|
|
|
|
|
|
|
|
BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
TCRR / Tcr2 Therapeutics Inc
|
|
|
|
|
|
|
|
SLRN / Acelyrin, Inc.
|
|
|
|
|
|
|
|
CNC / Centene Corporation
|
|
|
|
|
|
|
|
/ ONCOLOGY INSTITUTE INC/THE
|
|
|
|
|
|
|
|
ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
JAZZ / Jazz Pharmaceuticals plc
|
|
|
|
|
|
|
|
LVTX / LAVA Therapeutics N.V.
|
|
|
|
|
|
|
|
BSX / Boston Scientific Corporation
|
|
|
|
|
|
|
|
PEN / Penumbra, Inc.
|
|
|
|
|
|
|
|
KYMR / Kymera Therapeutics, Inc.
|
|
|
|
|
|
|
|
BEAM / Beam Therapeutics Inc.
|
|
|
|
|
|
|
|
SRRK / Scholar Rock Holding Corporation
|
|
|
|
|
|
|
|
MDVL / MedAvail Holdings, Inc.
|
|
|
|
|
|
|
|
HOOK / HOOKIPA Pharma Inc.
|
|
|
|
|
|
|
|
BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
MRSN / Mersana Therapeutics, Inc.
|
|
|
|
|
|
|
|
TKNO / Alpha Teknova, Inc.
|
|
|
|
|
|
|
|
CTSO / Cytosorbents Corporation
|
|
|
|
|
|
|
|
EVH / Evolent Health, Inc.
|
|
|
|
|
|
|
|
ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
ELV / Elevance Health, Inc.
|
|
|
|
|
|
|
|
ANNX / Annexon, Inc.
|
|
|
|
|
|
|
|
HUM / Humana Inc.
|
|
|
|
|
|
|
|
VTYX / Ventyx Biosciences, Inc.
|
|
|
|
|
|
|
|
IQV / IQVIA Holdings Inc.
|
|
|
|
|
|
|
|
ADCT / ADC Therapeutics SA
|
|
|
|
|
|
|
|
STTK / Shattuck Labs, Inc.
|
|
|
|
|
|
|
|
ATRA / Atara Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
LIVN / LivaNova PLC
|
|
|
|
|
|
|
|
IVVD / Invivyd, Inc.
|
|
|
|
|
|
|
|
COGT / Cogent Biosciences, Inc.
|
|
|
|
|
|
|
|
NVTA / Invitae Corporation
|
|
|
|
|
|
|
|
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ALVR / AlloVir, Inc.
|
|
|
|
|
|
|
|
KRYS / Krystal Biotech, Inc.
|
|
|
|
|
|
|
|
STXS / Stereotaxis, Inc.
|
|
|
|
|
|
|
|
ALLK / Allakos Inc.
|
|
|
|
|
|
|
|
FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
ALXO / ALX Oncology Holdings Inc.
|
|
|
|
|
|
|
|
ETNB / 89bio, Inc.
|
|
|
|
|
|
|
|
RGNX / REGENXBIO Inc.
|
|
|
|
|
|
|
|
CRL / Charles River Laboratories International, Inc.
|
|
|
|
|
|
|
|
XERS / Xeris Biopharma Holdings, Inc.
|
|
|
|
|
|
|
|
LSAQ / LifeSci Acquisition II Corp
|
|
|
|
|
|
|
|
BCEL / Atreca, Inc.
|
|
|
|
|
|
|
|
PLRX / Pliant Therapeutics, Inc.
|
|
|
|
|
|
|
|
IGMS / IGM Biosciences, Inc.
|
|
|
|
|
|
|
|
AUGX / Augmedix, Inc.
|
|
|
|
|
|
|
|
VERV / Verve Therapeutics, Inc.
|
|
|
|
|
|
|
|
REPL / Replimune Group, Inc.
|
|
|
|
|
|
|
|
CTLT / Catalent, Inc.
|
|
|
|
|
|
|
|
SYK / Stryker Corporation
|
|
|
|
|
|
|
|
NRIX / Nurix Therapeutics, Inc.
|
|
|
|
|
|
|
|
IMVT / Immunovant, Inc.
|
|
|
|
|
|
|
|
GRTSQ / Gritstone bio, Inc.
|
|
|
|
|
|
|
|
NUVB / Nuvation Bio Inc.
|
|
|
|
|
|
|
|
RPTX / Repare Therapeutics Inc.
|
|
|
|
|
|
|
|
ABSI / Absci Corporation
|
|
|
|
|
|
|
|
TRDA / Entrada Therapeutics, Inc.
|
|
|
|
|
|
|
|
STOK / Stoke Therapeutics, Inc.
|
|
|
|
|
|
|
|
RAPT / RAPT Therapeutics, Inc.
|
|
|
|
|
|
|
|
PRME / Prime Medicine, Inc.
|
|
|
|
|
|
|
|